168 related articles for article (PubMed ID: 31047753)
1. Position of lipidation influences anticancer activity of Smac analogs.
Micewicz ED; Nguyen C; Micewicz A; Waring AJ; McBride WH; Ruchala P
Bioorg Med Chem Lett; 2019 Jul; 29(13):1628-1635. PubMed ID: 31047753
[TBL] [Abstract][Full Text] [Related]
2. Lipid-conjugated Smac analogues.
Micewicz ED; Ratikan JA; Waring AJ; Whitelegge JP; McBride WH; Ruchala P
Bioorg Med Chem Lett; 2015 Oct; 25(20):4419-27. PubMed ID: 26384289
[TBL] [Abstract][Full Text] [Related]
3. Promises and Challenges of Smac Mimetics as Cancer Therapeutics.
Fulda S
Clin Cancer Res; 2015 Nov; 21(22):5030-6. PubMed ID: 26567362
[TBL] [Abstract][Full Text] [Related]
4. IAP Proteins Antagonist: An Introduction and Chemistry of Smac Mimetics under Clinical Development.
Ali R; Singh S; Haq W
Curr Med Chem; 2018; 25(31):3768-3795. PubMed ID: 29532750
[TBL] [Abstract][Full Text] [Related]
5. Novel dimeric Smac analogs as prospective anticancer agents.
Micewicz ED; Luong HT; Jung CL; Waring AJ; McBride WH; Ruchala P
Bioorg Med Chem Lett; 2014 Mar; 24(6):1452-7. PubMed ID: 24582479
[TBL] [Abstract][Full Text] [Related]
6. Smac mimetics as new cancer therapeutics.
Chen DJ; Huerta S
Anticancer Drugs; 2009 Sep; 20(8):646-58. PubMed ID: 19550293
[TBL] [Abstract][Full Text] [Related]
7. A novel SMAC mimetic APG-1387 exhibits dual antitumor effect on HBV-positive hepatocellular carcinoma with high expression of cIAP2 by inducing apoptosis and enhancing innate anti-tumor immunity.
Pan W; Luo Q; Yan X; Yuan L; Yi H; Zhang L; Li B; Zhang Y; Sun J; Qiu MZ; Yang DJ
Biochem Pharmacol; 2018 Aug; 154():127-135. PubMed ID: 29679556
[TBL] [Abstract][Full Text] [Related]
8. SMAC mimetics sensitize nonsteroidal anti-inflammatory drug-induced apoptosis by promoting caspase-3-mediated cytochrome c release.
Bank A; Wang P; Du C; Yu J; Zhang L
Cancer Res; 2008 Jan; 68(1):276-84. PubMed ID: 18172320
[TBL] [Abstract][Full Text] [Related]
9. Design of small-molecule Smac mimetics as IAP antagonists.
Wang S
Curr Top Microbiol Immunol; 2011; 348():89-113. PubMed ID: 21072626
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of a novel homodimeric SMAC mimetic in ovarian carcinoma.
Gatti L; De Cesare M; Ciusani E; Corna E; Arrighetti N; Cominetti D; Belvisi L; Potenza D; Moroni E; Vasile F; Lecis D; Delia D; Castiglioni V; Scanziani E; Seneci P; Zaffaroni N; Perego P
Mol Pharm; 2014 Jan; 11(1):283-93. PubMed ID: 24256025
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of smac mimetics; chemotype differentiation based on physical association with caspase regulators and cellular transport.
Talbott RL; Borzilleri RM; Chaudhry C; Fargnoli J; Shen H; Fairchild C; Barnhart B; Ortega M; McDonagh TE; Vuppugalla R; Vite GD; Hunt JT; Gottardis M; Naglich JG
Exp Cell Res; 2015 Nov; 338(2):251-60. PubMed ID: 26302264
[TBL] [Abstract][Full Text] [Related]
12. Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines.
Cekay MJ; Roesler S; Frank T; Knuth AK; Eckhardt I; Fulda S
Cancer Lett; 2017 Dec; 410():228-237. PubMed ID: 28923396
[TBL] [Abstract][Full Text] [Related]
13. The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma.
Matzinger O; Viertl D; Tsoutsou P; Kadi L; Rigotti S; Zanna C; Wiedemann N; Vozenin MC; Vuagniaux G; Bourhis J
Radiother Oncol; 2015 Sep; 116(3):495-503. PubMed ID: 26096848
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Small Molecules Target Inhibitor of Apoptosis Proteins in Cancers with Deregulation of Extrinsic and Intrinsic Cell Death Pathways.
Derakhshan A; Chen Z; Van Waes C
Clin Cancer Res; 2017 Mar; 23(6):1379-1387. PubMed ID: 28039268
[TBL] [Abstract][Full Text] [Related]
15. Smac mimetics as novel promising modulators of apoptosis in the treatment of breast cancer.
Nikkhoo A; Rostami N; Hojjat-Farsangi M; Azizi G; Yousefi B; Ghalamfarsa G; Jadidi-Niaragh F
J Cell Biochem; 2019 Jun; 120(6):9300-9314. PubMed ID: 30506843
[TBL] [Abstract][Full Text] [Related]
16. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.
Fulda S; Wick W; Weller M; Debatin KM
Nat Med; 2002 Aug; 8(8):808-15. PubMed ID: 12118245
[TBL] [Abstract][Full Text] [Related]
17. Combination effects of SMAC mimetic birinapant with TNFα, TRAIL, and docetaxel in preclinical models of HNSCC.
Eytan DF; Snow GE; Carlson SG; Schiltz S; Chen Z; Van Waes C
Laryngoscope; 2015 Mar; 125(3):E118-24. PubMed ID: 25431358
[TBL] [Abstract][Full Text] [Related]
18. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
Bockbrader KM; Tan M; Sun Y
Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
[TBL] [Abstract][Full Text] [Related]
19. The IAP Protein Family, SMAC Mimetics and Cancer Treatment.
Philchenkov A; Miura K
Crit Rev Oncog; 2016; 21(3-4):185-202. PubMed ID: 27915971
[TBL] [Abstract][Full Text] [Related]
20. Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice.
Shekhar TM; Burvenich IJG; Harris MA; Rigopoulos A; Zanker D; Spurling A; Parker BS; Walkley CR; Scott AM; Hawkins CJ
BMC Cancer; 2019 Sep; 19(1):924. PubMed ID: 31521127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
